This document is a publication of a new patent application (US20260085293A1) filed with the USPTO on March 27, 2024. The application describes a novel solution and method for transporting or storing body fluid samples, featuring an active ingredient selected from a group including kanamycin, G418, streptomycin, maltotriose, N-acetylmuramic acid, and glucose.

While this is a patent application and not a regulation imposing direct compliance obligations, it signifies potential future developments in biotechnology and medical sample handling. Companies involved in diagnostic testing, pharmaceutical research, or medical device manufacturing should be aware of this innovation as it may influence future product development, intellectual property landscapes, and best practices in sample integrity.